RIVILY
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99500953
- Mark type
- Stylized text
- Filed
- 17 Nov 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Brent A. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss
Owner
- Axsome Therapeutics, Inc., New York, NY, US
- Axsome Therapeutics, Inc., New York, NY, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jan 2026 — ASSIGNED TO EXAMINER
- 17 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Nov 2025 — NEW APPLICATION ENTERED